Interleukin-22 activates STAT3 and induces IL-10 by colon epithelial cells.
about
Interleukin-22 Signaling in the Regulation of Intestinal Health and DiseaseWhen Insult Is Added to Injury: Cross Talk between ILCs and Intestinal Epithelium in IBDInvolvement of the IL-22/REG Ialpha axis in ulcerative colitisA human natural killer cell subset provides an innate source of IL-22 for mucosal immunityAn antibiotic-responsive mouse model of fulminant ulcerative colitisInterleukin-10 suppression of myeloid cell activation--a continuing puzzle.Chitinase 3-like 1 synergistically activates IL6-mediated STAT3 phosphorylation in intestinal epithelial cells in murine models of infectious colitis.High systemic levels of interleukin-10, interleukin-22 and C-reactive protein in Indian patients are associated with low in vitro replication of HIV-1 subtype C virusesThe Anti-Hiv Candidate Abx464 Dampens Intestinal Inflammation by Triggering Il-22 Production in Activated Macrophages.Interleukin-22 suppresses the growth of A498 renal cell carcinoma cells via regulation of STAT1 pathway.Stat3: linking inflammation to epithelial cancer - more than a "gut" feeling?IL-22 is produced by innate lymphoid cells and limits inflammation in allergic airway diseaseIncreased Tc22 and Treg/CD8 ratio contribute to aggressive growth of transplant associated squamous cell carcinoma.IL-22 mediates goblet cell hyperplasia and worm expulsion in intestinal helminth infection.Interleukin-22 promotes T helper 1 (Th1)/Th17 immunity in chlamydial lung infectionIL22/IL-22R pathway induces cell survival in human glioblastoma cells.Interleukin-22: immunobiology and pathology.Expression of interleukin-22 in Sjögren's syndrome: significant correlation with disease parametersLiver immunobiology.Cooperation between the bacterial-derived short-chain fatty acid butyrate and interleukin-22 detected in human Caco2 colon epithelial/carcinoma cells.Aberrant expression of IL-22 receptor 1 and autocrine IL-22 stimulation contribute to tumorigenicity in ALK+ anaplastic large cell lymphoma.Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammationrIL-22 as an adjuvant enhances the immunogenicity of rGroEL in mice and its protective efficacy against S. Typhi and S. Typhimurium.IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitisDistinct, specific IL-17- and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune responseInterleukin-22 forms dimers that are recognized by two interleukin-22R1 receptor chains.IL-22 regulation of functional gene expression in salivary gland cells.Expression of interleukin-22/STAT3 signaling pathway in ulcerative colitis and related carcinogenesis.Regulation of FoxP3 regulatory T cells and Th17 cells by retinoids.IL-22 in the endometriotic milieu promotes the proliferation of endometrial stromal cells via stimulating the secretion of CCL2 and IL-8Role of STAT3 in inflammatory bowel diseaseTNF-α augments RANKL-dependent intestinal M cell differentiation in enteroid cultures.A role for IL-22 in the relationship between intestinal helminths, gut microbiota and mucosal immunity.Function of the intestinal epithelium and its dysregulation in inflammatory bowel disease.Immune functioning in non lymphoid organs: the liver.IL-10 and IL-10 receptor defects in humans.Healing of intestinal inflammation by IL-22.IL-22: An Evolutionary Missing-Link Authenticating the Role of the Immune System in Tissue Regeneration.IL-22, not simply a Th17 cytokine.IL-22 in tissue-protective therapy.
P2860
Q26770224-E5FF6C1D-2FBF-4B9E-BB38-ED64C9D0C02EQ28079656-58FE3449-53F1-4F76-A5D5-06BDFABBCED4Q28270049-5602DD55-7EDD-4E1D-97F7-CBA07ADD8C0FQ28299539-BF58B1E2-1DC0-4287-A863-B44B6BD43E97Q33322360-6D561B73-6838-47C3-B27C-5C823C3ABA65Q33340529-0B2EF90E-CEC9-46F2-A913-61F278A53752Q33576348-BED1EE32-31C4-4835-976E-13199070E77AQ33736978-00EA6F84-90EB-4BFF-B122-28221DD43772Q33884876-B3B12B58-F0CE-4502-AFCE-96D2069C4FCAQ33916153-B02E63D4-147F-4565-965A-4E15516F90E6Q33921803-18C6D9A6-4A49-43D3-AA25-E8E790ADE558Q33971114-C867E553-8941-4F1E-A145-DBDCB410FCA6Q34717034-D82F4F7A-EB0F-49B1-97FF-CA59FD22A253Q35018086-1DC97C37-5210-43A5-8294-1C1F3077EDA2Q35095074-9CDE5721-E06C-49C9-8793-4B661F80B4B3Q35203455-F5F2EA41-8A90-4E59-A4F7-217F5AA36B5CQ35530956-BE784FAD-245C-4456-97EA-0EA5747B47B5Q35647194-2BE0EFF0-55F3-4F31-A9BE-4EFFBDBB68E1Q36086411-3FF37EB7-0902-43B1-8B9C-FB7F84EB3F1CQ36179133-CB9BB0C6-85E3-4D41-B18F-05BC5D5F0BF0Q36193920-071C46A7-FC65-437A-8E68-060BD126BB39Q36291657-8DD00B49-B6EF-46EA-9A97-15CBEB11D9B0Q36302839-1EA418B0-8C6C-43B0-9863-A8853EF20EDEQ36303708-E545DE28-DDF1-4A1C-98FA-5946CC447652Q36416118-77DCF86E-FDAC-4ECB-BC62-218F8DB8D99BQ36459059-8BBF5D61-9277-45ED-B138-F98372F8E0CDQ36652620-372FB256-802A-4045-94FD-5BF879E9308EQ36819589-25BE9A98-DB57-4F4D-B9B5-3B459ACA7489Q37128687-D4F85D84-3F30-4B98-864E-68E22F8FDB6BQ37228800-3DE7F3EE-E047-4F28-96BD-78864B271B0DQ37262986-AEA4C40F-E049-41AC-A6DA-41F505351E89Q37457062-4237CCCD-FC1D-4BFD-83C0-C514F56AC1E7Q37640462-A41A30E7-51FF-4AB3-9C4C-170410560E97Q37774322-17526CC8-92DE-4C4B-AE81-7A69F59C76A2Q37957001-56978D94-CB01-4E34-B453-7E19E9D9CE4CQ37974986-7E620CC2-1EF0-49D0-84C5-455785A8D741Q37987526-856162F8-CF92-443F-9FA2-DA1541A17440Q38079587-8B627C75-38A9-4F1A-B744-6DE141E4ECF0Q38081171-5B3E06E4-F961-4DB7-85C3-4AE6D86D1787Q38093227-4418DA30-4961-48FC-A818-60B8167A7FA2
P2860
Interleukin-22 activates STAT3 and induces IL-10 by colon epithelial cells.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Interleukin-22 activates STAT3 and induces IL-10 by colon epithelial cells.
@en
type
label
Interleukin-22 activates STAT3 and induces IL-10 by colon epithelial cells.
@en
prefLabel
Interleukin-22 activates STAT3 and induces IL-10 by colon epithelial cells.
@en
P2093
P1476
Interleukin-22 activates STAT3 and induces IL-10 by colon epithelial cells
@en
P2093
Anne Rascle
Marehalli L Nagalakshmi
Sandra Zurawski
Satish Menon
P304
P356
10.1016/J.INTIMP.2004.01.008
P577
2004-05-01T00:00:00Z